,

Free Anti-Adalimumab

Detecting the development of Anti-drug antibodies (ADAs) against Adalimumab in patients being treated with Adalimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient.
AFIAS Free Anti-Adalimumab can detect the presence of anti-drug antibodies against
Adalimumab, requiring only a small amount of human serum or whole blood,
and delivering results in a mere 12 minutes. This allows physicians to verify the
presence of anti-drug antibodies immediately before the next administration.

Reviews

There are no reviews yet.

Be the first to review “Free Anti-Adalimumab”

Your email address will not be published. Required fields are marked *

Scroll to Top